Support the redevelopment of SCARD
As we reflect on the inaugural year of Skin Cancer Audit and Research Data Inc (SCARD Inc), we announce the official recognition as a Charity.
The Journey of Transformation: Company to Charity
As we reflect on the inaugural year of Skin Cancer Audit and Research Data Inc (SCARD Inc), we announce the official recognition as a Charity.
A joint announcement between SCARD Systems and SCARD Inc
As we reflect on the inaugural year of Skin Cancer Audit and Research Data Inc (SCARD Inc), we announce the official recognition as a Charity.
2023 – A year in review for SCARD
As our founding year, 2023 has been a pivotal year for SCARD, marked by significant advancements in skin cancer research, data analysis, and medical practice. The articles published on the SCARD website throughout the year offer valuable insights into various aspects of skin cancer management.
Data security: the platforms behind SCARD
With regular reports of data breaches worldwide, security and compliance are a continuous focus of Skin Cancer Audit and Research Data Inc for the deidentified skin cancer results and databases we maintain.
This article is intended to provide information on the technology used by SCARD Inc for the collection and storage of data as well as the security and compliance measures undertaken.
Practitioner characteristics, diagnostic accuracy metrics and discovering-individual
The fifth publication utilizing SCARD (and part of 3 papers by the same research team) was published in April 2023 with the Australasian Journal of Dermatology